학술논문
Effectiveness of the ten-valent pneumococcal Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Document Type
Article
Author
Source
The Lancet; January 2013, Vol. 381 Issue: 9862 p214-222, 9p
Subject
Language
ISSN
01406736; 1474547X
Abstract
The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype-specific polysaccharides conjugated to Haemophilus influenzaeprotein D, tetanus toxoid, and diphtheria toxoid as the carrier proteins (PHiD-CV10) against invasive pneumococcal disease.